Page 124 - Mployee Wellness Programs News Today

Medivis recently raised $20 million in a Series A funding round that included investments from Mayo Clinic, Bob Iger and Kevin Durant. The New York City-based company's technology can be thought of as a “virtual GPS system” for surgeons — it helps them navigate complex anatomical landscapes during operations and gives them a more accurate, intuitive understanding of the anatomy with which they're dealing.

Most patients prefer in-person care to virtual, according to a recent report. This finding should drive health systems to refine their telehealth experiences — they should determine which type of visits are best-suited for the modality, and they should ensure their virtual care environments adopt a more human-centric design.

Eli Lilly's partnership with Verve Therapeutics covers the development of a preclinical therapy addressing a protein associated with cardiovascular disease risk. The in vivo gene-editing therapy is a potential one-time treatment.

A new report by NORC at the University of Chicago reveals earlier enrollment in hospice and longer lengths of stay increase patient and family satisfaction while lowering total costs of care – reaffirming what hospice providers have known for years.

Many health systems aren’t employing the right tactics for hiring and retaining nurses, according to a new report. It argued that hospitals would have an easier time hiring and retaining nurses if they focused more on the things workers want most from their employers — such as flexible scheduling and professional development opportunities.

Ipsen drug Bylvay is now FDA approved for treating pruritus, or severe itching, which is a complication of the rare liver disease Alagille syndrome. The oral drug was previously approved for treating pruritus in another rare inherited liver disease called PFIC.

Healthcare executives must recognize the 10,000-piece cybersecurity puzzle is more likely solved by engaging leaders throughout the organization to share in responsibility instead of dropping the box of pieces on the desk of the CIO to solve alone.

Cala Health recently launched its kIQ system — which it calls the first noninvasive wearable device cleared by the FDA to temporarily relieve tremors in people with essential tremor and Parkinson’s disease.

2seventy Bio reported that an acute myeloid leukemia patient treated with its experimental cell therapy has died, prompting research partner Seattle Children’s Research Institute to pause the Phase 1 study. The FDA has been notified and an investigation is underway.

One of the fastest-growing frontiers of healthcare is Digital Therapeutics (DTx), which utilizes clinically tested software to prevent, treat, and manage a growing range of medical conditions. During Covid-19, governing agencies loosened regulatory requirements and increased incentives for DTx. Fortunately, this propelled innovation, and transitioned DTx from up-and-coming to a high-demand field. The goal was simple: provide access and focused support to patients remotely while simultaneously r...